These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3032432)

  • 21. Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors.
    Aghajanian GK
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):20-4. PubMed ID: 6282816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organization of noradrenergic efferents to arousal-related basal forebrain structures.
    España RA; Berridge CW
    J Comp Neurol; 2006 Jun; 496(5):668-83. PubMed ID: 16615125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder.
    Gold PW; Pigott TA; Kling MA; Kalogeras K; Chrousos GP
    Psychiatr Clin North Am; 1988 Jun; 11(2):327-34. PubMed ID: 3047702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenergic control of cognition: global attenuation and an interrupt function.
    David Johnson J
    Med Hypotheses; 2003 May; 60(5):689-92. PubMed ID: 12710903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvement of post-training performance 4 weeks after stimulation of the locus coeruleus in rats : absence of an effect of a lesion of the dorsal noradrenergic bundle].
    Velley L; Cardo B; Kempf E
    C R Seances Acad Sci III; 1981 May; 292(16):943-6. PubMed ID: 6790192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.
    Pols H; Griez E; Verburg K; van der Werf D
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):81-5. PubMed ID: 7948058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.
    Dierssen M; Gratacòs M; Sahún I; Martín M; Gallego X; Amador-Arjona A; Martínez de Lagrán M; Murtra P; Martí E; Pujana MA; Ferrer I; Dalfó E; Martínez-Cué C; Flórez J; Torres-Peraza JF; Alberch J; Maldonado R; Fillat C; Estivill X
    Neurobiol Dis; 2006 Nov; 24(2):403-18. PubMed ID: 16963267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of lesions of the locus coeruleus and treatment with drugs affecting brain noradrenergic neurotransmission on dominant-subordinate behavior in rats competing for water.
    Plewako M; Kostowski W
    Pol J Pharmacol Pharm; 1984; 36(5):555-60. PubMed ID: 6099891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical aspects of anxiety].
    Boulenger JP; Uhde TW
    Sem Hop; 1982 Dec; 58(44):2573-9. PubMed ID: 6130605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of CO2 challenges.
    Griez E; Schruers K
    J Psychopharmacol; 2003 Sep; 17(3):260-2; discussion 267-8. PubMed ID: 14513914
    [No Abstract]   [Full Text] [Related]  

  • 31. [Panic: physiology and psychology].
    Fiume S
    Minerva Psichiatr; 1989; 30(3):215-21. PubMed ID: 2607942
    [No Abstract]   [Full Text] [Related]  

  • 32. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.
    Sullivan GM; Coplan JD; Kent JM; Gorman JM
    Biol Psychiatry; 1999 Nov; 46(9):1205-18. PubMed ID: 10560026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of the hypothalamus-pituitary-adrenal cortex axis by locus ceruleus and central noradrenergic system].
    Wang FZ; Wang YJ
    Sheng Li Ke Xue Jin Zhan; 1982 Jul; 13(3):208-12. PubMed ID: 6294824
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on brain noradrenergic neurons in animal model for antidepressive activity.
    Kostowski W; Danysz W; Nowakowska E
    Psychopharmacol Bull; 1984; 20(2):320-2. PubMed ID: 6728997
    [No Abstract]   [Full Text] [Related]  

  • 35. Nocturnal panic in a depressed patient: pathophysiological implications.
    Herman R
    Biol Psychiatry; 1988 Aug; 24(4):432-6. PubMed ID: 3255287
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of locus coeruleus and periventricular gray substance lesions on suprachiasmatic damage-induced persistent estrous.
    Solano-Flores LP; Donatti-Albarrán OA; Guevara-Aguilar R
    Brain Res Bull; 1987 Mar; 18(3):429-35. PubMed ID: 3580912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical noradrenaline, attention and arousal.
    Robbins TW
    Psychol Med; 1984 Feb; 14(1):13-21. PubMed ID: 6709778
    [No Abstract]   [Full Text] [Related]  

  • 38. Panic attacks: new approaches to an old problem.
    Gelder MG
    Br J Psychiatry; 1986 Sep; 149():346-52. PubMed ID: 3779301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locus coeruleus reports changes in environmental contingencies.
    Sara SJ
    Behav Brain Sci; 2016 Jan; 39():e223. PubMed ID: 28347363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity.
    Charney DS; Redmond DE
    Neuropharmacology; 1983 Dec; 22(12B):1531-6. PubMed ID: 6142428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.